Dr. Jian Zeng 曾剑
Chief Physician
Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of thoracic tumors, with extensive clinical experience in surgery for lung cancer, esophageal cancer, mediastinal tumors, and cardia cancer.
Dr. Zeng is a Chief Physician and holds a doctorate in thoracic surgery. Serving as Deputy Director of Thoracic Surgery and Ward Director, Dr. Zeng studied minimally invasive surgical techniques for thoracic tumors at Evangelisches Krankenhaus in Germany in 2013. Research focuses on early diagnosis and treatment of lung cancer, postoperative nutrition for esophageal cancer patients, and quality of life after thoracic tumor surgery.
Name order: in Chinese the family name comes first (Zeng Jian). Papers usually list the name as Jian Zeng or Zeng J.
Selected publications
51 papers on PubMed matched by name and affiliation; 23 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMJ Open, 2026 (senior author): Neoadjuvant QL1706 plus chemotherapy in patients with stage II-IIIB squamous non-small cell lung cancer: study protocol for a prospective, single-arm, multicentre phase II trial. PubMed 42772869
- Transl Lung Cancer Res, 2026 (senior author): Neoadjuvant befotertinib plus vorolanib in resectable stage II-IIIB EGFR-mutant NSCLC: a study protocol for the prospective, single-arm phase I/II trial. PubMed 42582862
- Sci Rep, 2026 (senior author): Construction and mechanism of histone deacetylation related gene prognosis model in esophageal carcinoma. PubMed 42471418
- J Thorac Cardiovasc Surg, 2026 (senior author): Pathologic response and nodal status guide adjuvant immunotherapy in non-small cell lung cancer after neoadjuvant chemoimmunotherapy: An eastern Asian cohort study. PubMed 41765326
- J Thorac Dis, 2025 (senior author): Lower r-FEV1 as a predictor of treatment response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy. PubMed 40950884
- J Thorac Dis, 2025 (senior author): Lobectomy versus sub-lobar resection for special type non-small cell lung cancer ≤2 cm. PubMed 40688273
- Dis Esophagus, 2025 (senior author): Recurrence patterns following neoadjuvant chemotherapy combined with immunotherapy for esophageal squamous cell carcinoma. PubMed 40386863
- Ann Thorac Cardiovasc Surg, 2025 (senior author): The Positioning Method of Pulmonary Nodules in Thoracoscopic Surgery Based on CT Simulation Positioning System for Radiotherapy. PubMed 40189280
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion